Matches in SemOpenAlex for { <https://semopenalex.org/work/W4379618635> ?p ?o ?g. }
- W4379618635 endingPage "104636" @default.
- W4379618635 startingPage "104636" @default.
- W4379618635 abstract "The complex tumor microenvironment often hinders the efficient delivery of anticancer therapeutics to the individual tumor cells following three levels of drug disposition. Carrying out trials and tests using animal models for screening of anticancer pharmaceuticals and studying their pharmacokinetics is an unavoidable step before reaching it from bench-to-bedside application. However, various factors like the expenses, time needed to obtain ethical clearances and to achieve conclusive results, have added to the complications of this process. Tumor spheroids have helped in overcoming most of the above-mentioned issues for obtaining promising pre-clinical quick validations, offering a successful diffusion of anticancer pharmaceuticals, leading the testing, screening, and studying the penetration, reaction, stability, and other pharmacokinetic characteristics of anticancer therapeutics rapid, cost effective and more efficient without involving any ethical issues, making it a promising platform for screening and assessment of effectiveness of anticancer pharmaceuticals in anticancer therapy. Finally, we emphasize the impact of nanomedicine's physiochemical characteristics (size, shape, surface charge and surface modifications) on their ability to penetrate and retain within tumor spheroids. It also discusses how the inclusion of 3D in vitro models into screening protocols can improve the efficacy of nanomedicine." @default.
- W4379618635 created "2023-06-08" @default.
- W4379618635 creator A5000181555 @default.
- W4379618635 creator A5021506401 @default.
- W4379618635 creator A5027248708 @default.
- W4379618635 creator A5027864788 @default.
- W4379618635 creator A5036419534 @default.
- W4379618635 creator A5050741118 @default.
- W4379618635 creator A5055808371 @default.
- W4379618635 creator A5057038217 @default.
- W4379618635 creator A5057942250 @default.
- W4379618635 creator A5061837453 @default.
- W4379618635 creator A5064594498 @default.
- W4379618635 creator A5067133188 @default.
- W4379618635 creator A5075291519 @default.
- W4379618635 creator A5077128500 @default.
- W4379618635 creator A5080050959 @default.
- W4379618635 creator A5086989058 @default.
- W4379618635 date "2023-09-01" @default.
- W4379618635 modified "2023-10-05" @default.
- W4379618635 title "3D multicellular tumor spheroids used for in vitro preclinical therapeutic screening" @default.
- W4379618635 cites W1523453062 @default.
- W4379618635 cites W1602237897 @default.
- W4379618635 cites W1744054130 @default.
- W4379618635 cites W1944990631 @default.
- W4379618635 cites W1964066086 @default.
- W4379618635 cites W1964553162 @default.
- W4379618635 cites W1966653969 @default.
- W4379618635 cites W1970940601 @default.
- W4379618635 cites W1971620413 @default.
- W4379618635 cites W1972669686 @default.
- W4379618635 cites W1973678759 @default.
- W4379618635 cites W1986568717 @default.
- W4379618635 cites W1997813585 @default.
- W4379618635 cites W2000192722 @default.
- W4379618635 cites W2004049846 @default.
- W4379618635 cites W2005425158 @default.
- W4379618635 cites W2012867962 @default.
- W4379618635 cites W2034336070 @default.
- W4379618635 cites W2035252444 @default.
- W4379618635 cites W2035954579 @default.
- W4379618635 cites W2038966527 @default.
- W4379618635 cites W2046643396 @default.
- W4379618635 cites W2047209914 @default.
- W4379618635 cites W2048466758 @default.
- W4379618635 cites W2049772098 @default.
- W4379618635 cites W2053781426 @default.
- W4379618635 cites W2063275328 @default.
- W4379618635 cites W2064991606 @default.
- W4379618635 cites W2074103138 @default.
- W4379618635 cites W2076214664 @default.
- W4379618635 cites W2078412979 @default.
- W4379618635 cites W2086664688 @default.
- W4379618635 cites W2087658248 @default.
- W4379618635 cites W2091882385 @default.
- W4379618635 cites W2094082198 @default.
- W4379618635 cites W2096391616 @default.
- W4379618635 cites W2099905447 @default.
- W4379618635 cites W2100432154 @default.
- W4379618635 cites W2105017561 @default.
- W4379618635 cites W2105619762 @default.
- W4379618635 cites W2130234889 @default.
- W4379618635 cites W2132566055 @default.
- W4379618635 cites W2133379217 @default.
- W4379618635 cites W2135936873 @default.
- W4379618635 cites W2144499341 @default.
- W4379618635 cites W2148512402 @default.
- W4379618635 cites W2153305381 @default.
- W4379618635 cites W2154555172 @default.
- W4379618635 cites W2165122639 @default.
- W4379618635 cites W2165316896 @default.
- W4379618635 cites W2165836181 @default.
- W4379618635 cites W217156178 @default.
- W4379618635 cites W2189134497 @default.
- W4379618635 cites W2204421316 @default.
- W4379618635 cites W2226539427 @default.
- W4379618635 cites W2236643502 @default.
- W4379618635 cites W2275816640 @default.
- W4379618635 cites W2323548888 @default.
- W4379618635 cites W2331469956 @default.
- W4379618635 cites W2332155194 @default.
- W4379618635 cites W2335836427 @default.
- W4379618635 cites W2339267390 @default.
- W4379618635 cites W2372837803 @default.
- W4379618635 cites W2479858070 @default.
- W4379618635 cites W2509934805 @default.
- W4379618635 cites W2514762476 @default.
- W4379618635 cites W2515563756 @default.
- W4379618635 cites W2519860162 @default.
- W4379618635 cites W2539424880 @default.
- W4379618635 cites W2550597146 @default.
- W4379618635 cites W2553928733 @default.
- W4379618635 cites W2553948338 @default.
- W4379618635 cites W2555627105 @default.
- W4379618635 cites W2560282307 @default.
- W4379618635 cites W2588271989 @default.
- W4379618635 cites W2591628935 @default.
- W4379618635 cites W2612323044 @default.